Osiris Therapeutics, Inc. (OSIR)
$6.57
0.09 (+1.39%)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $6.48 |
| Daily Range | $6.49 - $6.64 |
| 52-Week Range | $5.35 - $21.65 |
| Market Cap | $215.31M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 178,608 |
| Average Daily Volume | 255,000 |
OSIR
VS S&P 500 (SPY)
How do you think OSIR will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
OSIR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
OSIR News and Commentary
- Cashing In on Obamacare – The Motley Fool
- BUY OR SELL-Will Osiris' stem cell dreams see daylight? – Reuters
- Fearful Stocks for Greedy Investors – The Motley Fool
- 3 Stocks in a Tailspin – The Motley Fool
- Fearful Stocks for Greedy Investors – The Motley Fool
- UPDATE 1-Osiris' stem cell drug fails in two late-stage trials – Reuters
- Trading – Blog at The Motley Fool
- 4-Star Stocks Poised to Pop: Genomic – The Motley Fool
- Monday's Biggest Stock Stars – The Motley Fool
- A Less-Risky Stem Cell Play – The Motley Fool
- Bankruptcy Watch – Blog at The Motley Fool
- Cruising, but Ready to Take Off – The Motley Fool
- Stem Cell Stocks Surge in Past Month – Blog at The Motley Fool
- Small cap biotech: The BAD (part I) – Blog at The Motley Fool
- A New Index of Emerging Biotech & Pharma Companies – Blog at The Motley Fool
- Regenerative Medicine: The Next Frontier for Big Pharma – Blog at The Motley Fool
- Cytori Therapeutics: Set for a Sale to Olympus? – Blog at The Motley Fool
- The Stem Cell 'Celution' for Success at Cytori Therapeutics – Blog at The Motley Fool
- Cytori's Stem Cell 'Celution' for Success – Blog at The Motley Fool
- Cytori Therapeutics: The Stem Cell 'Celution' for Success – Blog at The Motley Fool
RSS Headlines
Fool UK
